162 related articles for article (PubMed ID: 26063416)
1. PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.
Jernman J; Kallio P; Hagström J; Välimäki MJ; Haapasalo H; Alitalo K; Arola J; Haglund C
Virchows Arch; 2015 Sep; 467(3):279-84. PubMed ID: 26063416
[TBL] [Abstract][Full Text] [Related]
2. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
[TBL] [Abstract][Full Text] [Related]
3. Cyclin A predicts metastatic potential of rectal neuroendocrine tumors.
Jernman J; Välimäki MJ; Hagström J; Louhimo J; Haapasalo H; Arola J; Haglund C
Hum Pathol; 2014 Aug; 45(8):1605-9. PubMed ID: 24824027
[TBL] [Abstract][Full Text] [Related]
4. Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors.
Lai JP; Mertens RB; Mirocha J; Koo J; Venturina M; Chung F; Mendez AB; Kahn M; Dhall D
Endocr Pathol; 2015 Mar; 26(1):54-62. PubMed ID: 25433656
[TBL] [Abstract][Full Text] [Related]
5. Expression of Stem Cell-associated Marker HES77 in Rectal Neuroendocrine Tumors.
Jernman J; Hagström J; Mäenpää H; Välimäki MJ; Haapasalo H; Nilsson O; Fermér C; Haglund C; Arola J
Anticancer Res; 2015 Jul; 35(7):3767-72. PubMed ID: 26124320
[TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
[TBL] [Abstract][Full Text] [Related]
7. Rectal Neuroendocrine Tumor with Synchronous Pancreatic Metastasis: A Case Report.
Masuoka Y; Furukawa D; Yazawa N; Izumi H; Yamada M; Mashiko T; Saito G; Okada K; Tanaka A; Suzuki T; Sadahiro S; Hirabayashi K; Nakagohri T
Tokai J Exp Clin Med; 2018 Jul; 43(2):38-44. PubMed ID: 29961930
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.
Lin X; Saad RS; Luckasevic TM; Silverman JF; Liu Y
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):407-14. PubMed ID: 18091383
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A Expression in Rectal Neuroendocrine Tumors Is Associated With More Aggressive Clinical Behavior and a Poorer Prognosis.
Kim J; Kim JY; Oh EH; Yoo C; Park IJ; Yang DH; Ryoo BY; Ryu JS; Hong SM
Am J Surg Pathol; 2020 Nov; 44(11):1496-1505. PubMed ID: 32735108
[TBL] [Abstract][Full Text] [Related]
10. High PROX1 expression in gastric cancer predicts better survival.
Laitinen A; Böckelman C; Hagström J; Kokkola A; Kallio P; Haglund C
PLoS One; 2017; 12(8):e0183868. PubMed ID: 28854215
[TBL] [Abstract][Full Text] [Related]
11. Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis.
Kim JY; Kim KS; Kim KJ; Park IJ; Lee JL; Myung SJ; Park Y; Park YS; Yu CS; Kim JC; Yu E; Jang HJ; Hong SM
Am J Surg Pathol; 2015 May; 39(5):632-43. PubMed ID: 25724002
[TBL] [Abstract][Full Text] [Related]
12. The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
Koo J; Zhou X; Moschiano E; De Peralta-Venturina M; Mertens RB; Dhall D
Endocr Pathol; 2013 Dec; 24(4):184-90. PubMed ID: 24037217
[TBL] [Abstract][Full Text] [Related]
13. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters.
; Sohn JH; Cho MY; Park Y; Kim H; Kim WH; Kim JM; Jung ES; Kim KM; Lee JH; Chan HK; Park DY; Joo M; Kim S; Moon WS; Kang MS; Jin SY; Kang YK; Yoon SO; Han H; Choi E
Cancer Res Treat; 2015 Oct; 47(4):813-22. PubMed ID: 25715764
[TBL] [Abstract][Full Text] [Related]
15. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
[TBL] [Abstract][Full Text] [Related]
16. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
Miettinen M; Wang ZF
Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic value of transcription factor PROX1 in colorectal cancer.
Skog M; Bono P; Lundin M; Lundin J; Louhimo J; Linder N; Petrova TV; Andersson LC; Joensuu H; Alitalo K; Haglund CH
Br J Cancer; 2011 Oct; 105(9):1346-51. PubMed ID: 21970873
[TBL] [Abstract][Full Text] [Related]
18. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.
Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G
Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441
[TBL] [Abstract][Full Text] [Related]
19. Clusterin expression in gastrointestinal neuroendocrine tumours is highly correlated with location and is helpful in determining the origin of liver metastases.
Mourra N; Scriva A; Mansiaux Y; Gozlan S; Bennis M; Balaton A
Histopathology; 2014 Nov; 65(5):642-50. PubMed ID: 24807631
[TBL] [Abstract][Full Text] [Related]
20. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
